-
Signature
-
/s/ John Faurescu, attorney-in-fact for Mr. Blum
-
Stock symbol
-
CYTK
-
Transactions as of
-
Aug 1, 2023
-
Transactions value $
-
-$287,231
-
Form type
-
4
-
Date filed
-
8/1/2023, 04:57 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CYTK |
Common Stock |
Options Exercise |
$103K |
+10.7K |
+2.42% |
$9.65 |
452K |
Aug 1, 2023 |
Direct |
|
| transaction |
CYTK |
Common Stock |
Sale |
-$349K |
-10.7K |
-2.36% |
$32.63 |
441K |
Aug 1, 2023 |
Direct |
|
| transaction |
CYTK |
Common Stock |
Options Exercise |
$17.5K |
+1.81K |
+0.41% |
$9.65 |
443K |
Aug 1, 2023 |
Direct |
|
| transaction |
CYTK |
Common Stock |
Sale |
-$59K |
-1.81K |
-0.41% |
$32.63 |
441K |
Aug 1, 2023 |
Direct |
|
| holding |
CYTK |
Common Stock |
|
|
|
|
|
2.08K |
Aug 1, 2023 |
by Trust 1 |
F1 |
| holding |
CYTK |
Common Stock |
|
|
|
|
|
2.08K |
Aug 1, 2023 |
by Trust 2 |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CYTK |
Non-Qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-10.7K |
-51.67% |
$0.00 |
10K |
Aug 1, 2023 |
Common Stock |
10.7K |
$9.65 |
Direct |
|
| transaction |
CYTK |
Incentive Stock Option (Right to Buy) |
Options Exercise |
$0 |
-1.81K |
-13.38% |
$0.00 |
11.7K |
Aug 1, 2023 |
Common Stock |
1.81K |
$9.65 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: